男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

神經(jīng)氨酸酶(NEU)活性蛋白

Active Neuraminidase (NEU)

NEU1; SIAL1; Sialidase 1; Lysosomal Sialidase; Acetylneuraminyl hydrolase; G9 sialidase; N-acetyl-alpha-neuraminidase 1

  • 神經(jīng)氨酸酶(NEU)活性蛋白產(chǎn)品包裝(模擬)
  • 神經(jīng)氨酸酶(NEU)活性蛋白產(chǎn)品包裝(模擬)
  • APB611Hu01.jpgSDS-PAGE圖
  • 神經(jīng)氨酸酶(NEU)活性蛋白Figure. Western Blot; Sample: Recombinant NEU, Human.
  • Certificate通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

活性實(shí)驗(yàn)

NEU (Sialidase-1) is an enzyme that catalyzes the removal of sialic acid (N-acetylneuraminic acid) moities from glycoproteins and glycolipids. In the lysosome, this enzyme is part of a heterotrimeric complex together with beta-galactosidase and cathepsin A (CTSA). Thus a binding ELISA assay was conducted to detect the interaction of recombinant human NEU and recombinant human CTSA. Briefly, NEU were diluted serially in PBS, with 0.01%BSA (pH 7.4). Duplicate samples of 100uL were then transferred to CTSA-coated microtiter wells and incubated for 2h at 37°C. Wells were washed with PBST and incubated for 1h with anti-NEU pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37°C. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of NEU and CTSA was shown in Figure 1, and this effect was in a dose dependent manner.

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào)適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB611Hu05神經(jīng)氨酸酶(NEU)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPB611Hu02神經(jīng)氨酸酶(NEU)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPB611Hu01神經(jīng)氨酸酶(NEU)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPB611Hu03神經(jīng)氨酸酶(NEU)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APB611Hu01神經(jīng)氨酸酶(NEU)活性蛋白Cell?culture;?Activity?Assays.
APB611Hu02神經(jīng)氨酸酶(NEU)活性蛋白Cell?culture;?Activity?Assays.
RPB611Hu04神經(jīng)氨酸酶(NEU)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAB611Hu01神經(jīng)氨酸酶(NEU)多克隆抗體WB; IHC; ICC; IP.
PAB611Hu02神經(jīng)氨酸酶(NEU)多克隆抗體WB; IHC
LAB611Hu71神經(jīng)氨酸酶(NEU)多克隆抗體(生物素標(biāo)記)WB
LAB611Hu81神經(jīng)氨酸酶(NEU)多克隆抗體(異硫氰酸熒光素標(biāo)記)WB; IHC; ICC; IF.
MAB611Hu21神經(jīng)氨酸酶(NEU)單克隆抗體WB; IHC; ICC; IP.
SEB611Hu神經(jīng)氨酸酶(NEU)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.

參考文獻(xiàn)

雜志參考文獻(xiàn)
METHODS OF PREVENTING OR TREATING ATHEROSCLEROSIS WITH INHIBITORS OF SPECIFIC ISOENZYMES OF HUMAN NEURAMINIDASE[]